Marie Wood, MD

Professional Titles

• Professor

Recognitions

• William Smith Athletics 2013 Hosking Award, The William Smith College Heron Society (2013)

Publications

• Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline. Bedrosian I, Somerfield MR, Achatz MI, Boughey JC, Curigliano G, Friedman S, Kohlmann WK, Kurian AW, Laronga C, Lynce F, Norquist BS, Plichta JK, Rodriguez P, Shah PD, Tischkowitz M, Wood M, Yadav S, Yao K, Robson ME. J Clin Oncol. 2024 Feb 10;42(5):584-604. doi: 10.1200/JCO.23.02225. Epub 2024 Jan 4. PMID: 38175972
• Cancer Control . 2024 Jan-Dec:31:10732748241291609. doi: 10.1177/10732748241291609. Public Perspectives on Multi-Cancer Early Detection: A Qualitative Study Norah L Crossnohere 1, Nicola B Campoamor 2, Rosa Negash 1, Marie Wood 3, Jamie L Studts 3, Mohamed I Elsaid 2 4, Macarius Donneyong 5, Electra D Paskett 6, Daniel E Jonas 1, Daniel G Stover 4, Chyke A Doubeni 7, John F P Bridges 2 Affiliations Expand PMID: 39397323 PMCID: PMC11489936 DOI: 10.1177/10732748241291609
• Roy S, Lakritz S, Schreiber AR, Molina E, Kabos P, Wood M, Elias A, Kondapalli L, Bradley CJ, Diamond JR. Clinical outcomes of adjuvant taxane plus anthracycline versus taxane-based chemotherapy regimens in older adults with node-positive, triple-negative breast cancer: A SEER-Medicare study. Eur J Cancer. 2023 May;185:69-82. doi: 10.1016/j.ejca.2023.02.014. Epub 2023 Feb 28. PMID: 36965330.
• Daly MB, Pal T, Maxwell KN, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. J Natl Compr Canc Netw 2023;21(10):1000–1010.
• Paskett, ED, Subbiah N, Wood ME, Steffens C, Kaur JS, Adams-Campbell L, and S. George. Strategies to Increase Accrual of Underrepresented Populations in Alliance Cooperative Group Trials. Journal of Clinical Oncology, 2023. 41(16_suppl): p. 6509-6509
• Landry KK, Feldman HM, Nowak S, Taylor HL, Johns M, McKinnon W, Colello, LS, Nielson SM, Esplin ED, Greenblatt M and Marie E. Wood. Eliminating barriers to uptake of germline genetic testing for patients with advanced cancer: The GTAC study. Journal of Clinical Oncology, 2023. 41(16_suppl)
• Landry KK, Seward DJ, Dragon JA, Slavik M, Xu K, McKinnon WC, Colello L, Sweasy J, Wallace SS, Cuke M, Wood ME. Investigation of discordant sibling pairs from hereditary breast cancer families and analysis of a rare PMS1 variant. Cancer Genet. 2022 Jan;260-261:30-36. PubMed PMID: 34852986
• Landry KK, Lyon JL, Victoria KE, Changizzadeh PN, Cole BF, Pulluri B, Sikov WM, Wood ME. Weekly vs Every-3-Week Carboplatin with Weekly Paclitaxel in Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: A Retrospective Analysis. Breast Cancer (Dove Med Press). 2022;14:63-70. PubMed PMID: 35313558
• Xia YY, Gronwald J, Karlan B, Lubinski J, McCuaig JM, Brooks J, Moller P, Eisen A, Sun S, Senter L, Bordeleau L, Neuhausen SL, Singer CF, Tung N, Foulkes WD, Sun P, Narod SA, Kotsopoulos J. Contraceptive use and the risk of ovarian cancer among women with a BRCA1 or BRCA2 mutation. Gynecol Oncol. 2022 Mar;164(3):514-521. PubMed PMID: 35063280
• Geyer CE Jr, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španic T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer. Ann Oncol. 2022 Dec;33(12):1250-1268. PubMed PMID: 36228963

Practice Locations

UCHealth University of Colorado Hospital (UCH)
12605 E. 16th Ave
Aurora, CO 80045
720-848-0000

CU Medicine Medical Oncology - Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 101
Highlands Ranch, CO 80129
720-516-1100

UCHealth Hereditary Cancer Clinic - Anschutz Medical Campus
1665 Aurora Ct
Second Floor – Elevator B
Aurora, CO 80045
720-848-5944

Hospital Affiliation

• University of Colorado Hospital
• UCHealth Highlands Ranch Hospital

Specialty Information

Specialties

• Medical Oncology, Board Certification

Conditions & Treatments

• Cancers - Breast Cancer
• Cancers
• Cancers - Cancer Prevention